美股市场个股详情
BIIB 渤健公司
- 174.000
- -7.180-3.96%
收盘价 10/31 16:00 (美东)
- 174.210
- +0.210+0.12%
盘后 20:02 (美东)
253.55亿总市值15.73市盈率TTM
179.475最高价173.875最低价175.56万股成交量178.110今开181.180昨收3.08亿成交额1.21%换手率21.83市盈率(静)1.46亿总股本268.29552周最高1.55市净率252.62亿流通值173.87552周最低--股息TTM1.45亿流通股480.180历史最高--股息率TTM3.09%振幅2.625历史最低175.339平均价1股每手
关于渤健公司公司
生物基因公司是一家生物制药公司，从事神经和神经退行性疾病的发现、开发和提供治疗。其产品包括治疗多发性硬化症的TECFIDERA、VUMERITY、AVONEX、PLEGRIDY、TYSABRI和FAMPYRA，治疗SMA的SPINRAZA，治疗阿尔茨海默病的ADUHELM和治疗严重斑块性银屑病的FUMADERM。
公司介绍
公司代码BIIB
公司名称渤健公司
上市日期1991/09/17
发行价格15.00
成立日期1978
CEOMr. Christopher A. Viehbacher
所属市场纳斯达克
员工数量7570
年结日12-31
公司地址225 Binney Street
城市Cambridge
省份马萨诸塞州
国家美国
邮编02142
电话1-617-679-2000
董事高管
- 姓名
- 职务
- 年薪
- Christopher A. Viehbacher
- Director, President and Chief Executive Officer
- 406.99万
- Robin C. Kramer
- Senior Vice President and Chief Accounting Officer
- --
- Susan H. Alexander
- Executive Vice President and Chief Legal Officer
- 670.39万
- Michael R. Mcdonnell
- Executive Vice President and Chief Financial Officer
- 716.76万
- Dr. Ginger Gregory, PhD
- Executive Vice President and Chief Human Resources Officer
- --
- Adam Keeney, PhD
- Executive Vice President, Head of Corporate Development
- --
- Dr. Jane Grogan, PhD
- Executive Vice President, Head of Research
- --
- Nicole Murphy
- Executive Vice President, Pharmaceutical Operations and Technology
- 571.43万
- Dr. Priya Singhal, M.D.,M.P.H.
- Executive Vice President and Head of Development
- --
- Rachid Izzar
- Executive Vice President, Global Product Strategy and Commercialization
- 544.78万
- Caroline D. Dorsa
- Chairman of the Board
- 64.61万
- Dr. Eric K. Rowinsky,M.D.
- Independent Director
- 41.80万
- Susan Langer
- Independent Director
- 33.45万
- William A. Hawkins, III
- Independent Director
- 42.57万
- Dr. Lloyd Minor
- Independent Director
- --
- Monish D. Patolawala
- Independent Director
- --
- Professor Menelas Pangalos, PhD
- Independent Director
- --
- Jesus B. Mantas
- Independent Director
- 43.32万
- Dr. Maria C. Freire, PhD
- Independent Director
- 41.29万
- Dr. Stephen A. Sherwin, M.D.
- Independent Director
- 43.53万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据
